The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Ryanodine Receptor Blockade Reduces Amyloid-β Load and Memory Impairments in Tg2576 Mouse Model of Alzheimer Disease
Open accessAbstract
In Alzheimer disease (AD), the perturbation of the endoplasmic reticulum (ER) calcium (Ca 2+) homeostasis has been linked to presenilins, the catalytic core in γ-secretase complexes cleaving the amyloid precursor protein (APP), thereby generating amyloid-β (Aβ) peptides. Here we investigate whether APP contributes to ER Ca 2+homeostasis and whether ER Ca 2+could in turn influence Aβ production. We show that overexpression of wild-type human APP (APP 695), or APP harboring the Swedish double mutation (APP swe) triggers increased ryanodine receptor (RyR) expression and enhances RyR-mediated ER Ca 2+release in SH-SY5Y neuroblastoma cells and in APP swe-expressing (Tg2576) mice. Interestingly, dantrolene-induced lowering of RyR-mediated Ca 2+release leads to the reduction of both intracellular and extracellular Aβ load in neuroblastoma cells as well as in primary cultured neurons derived from Tg2576 mice. This Aβ reduction can be accounted for by decreased Thr-668-dependent APP phosphorylation and β- and γ-secretases activities. Importantly, dantrolene diminishes Aβ load, reduces Aβ-related histological lesions, and slows down learning and memory deficits in Tg2576 mice. Overall, our data document a key role of RyR in Aβ production and learning and memory performances, and delineate RyR-mediated control of Ca 2+homeostasis as a physiological paradigm that could be targeted for innovative therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Developments of a water-maze procedure for studying spatial learning in the rat
Morris, R. (1984) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(84)90007-4 · Cited by 7,180
Review Article: Genetics of Alzheimer Disease
Bekris, L. M., Yu, C.-E., Bird, T. D., & Tsuang, D. W. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710383571 · Cited by 1,029 · cited 1×
“As a support of the amyloid cascade hypothesis, most of the mutations in APP and PS1/PS2 responsible for early-onset familial AD (FAD) modulate A production (Bekris et al., 2010).”
BackgroundNeuronal calcium mishandling and the pathogenesis of Alzheimer's disease
Bezprozvanny, I., & Mattson, M. P. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.005 · Cited by 938
Jung, C. B., Moretti, A., Mederos y Schnitzler, M., Iop, L., Storch, U., Bellin, M., Dorn, T., Ruppenthal, S., Pfeiffer, S., Goedel, A., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100194 · Cited by 327 · cited 11×
“Interference of dantrolene with cardiac and neuronal RyR2 isoforms has been disputed, although it has recently been proposed to have effects on cardiac RyR2 (Jung et al., 2012; Maxwell et al., 2012).”
BackgroundInfluentialEfficacy and Safety of Memantine in Moderate-to-Severe Alzheimer Disease: The Evidence to Date
Bullock, R. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000201847.29836.a5 · Cited by 89 · cited 1×
“Although therapeutic approaches targeting Ca 2 influx have demonstrated efficacy in animal AD models, very few have been successful in clinical trials, namely, the L-type Ca 2 channel blocker nimodipine (Tollefson, 1990) and the NMDA open receptor blocker memantine (Bullock, 2006).”
Method
Cited by
Webster, S. J., Bachstetter, A. D., Nelson, P. T., Schmitt, F. A., & Van Eldik, L. J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00088 · Cited by 755
“Deficits in recognition memory do not appear until much later, first appearing at 12 months of age in the NOR task (Oules et al., 2012; Yassine et al., 2013).”
BackgroundCalcium signaling and molecular mechanisms underlying neurodegenerative diseases
Pchitskaya, E., Popugaeva, E., & Bezprozvanny, I. (2018) · Cell Calcium · doi:10.1016/j.ceca.2017.06.008 · Cited by 349
Obulesu, M., & Lakshmi, M. J. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1454-4 · Cited by 292
The biological pathways of Alzheimer disease: a review
Calabrò, M., Department of Biomedical and Dental Sciences and Morphofunctional Imaging, U. O. M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2021) · AIMS Neuroscience · doi:10.3934/neuroscience.2021005 · Cited by 265
Vaillant-Beuchot, L., Mary, A., Pardossi-Piquard, R., Bourgeois, A., Lauritzen, I., Eysert, F., Kinoshita, P. F., Cazareth, J., Badot, C., Fragaki, K., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-020-02234-7 · Cited by 263
Self-citationLauritzen, I., Pardossi-Piquard, R., Bourgeois, A., Pagnotta, S., Biferi, M.-G., Barkats, M., Lacor, P., Klein, W., Bauer, C., & Checler, F. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1577-6 · Cited by 219
Self-citationDi Benedetto, G., Burgaletto, C., Bellanca, C. M., Munafò, A., Bernardini, R., & Cantarella, G. (2022) · Cells · doi:10.3390/cells11172728 · Cited by 189
“[160] have reported that RyR-mediated Ca2+ release can be reduced after treatment with RyR inhibitor.”
BackgroundLacampagne, A., Liu, X., Reiken, S., Bussiere, R., Meli, A. C., Lauritzen, I., Teich, A. F., Zalk, R., Saint, N., Arancio, O., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1733-7 · Cited by 181
Self-citationChami, L., & Checler, F. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-52 · Cited by 168
“This agreed well with our recent work showing that the overexpression of both wild-type and Swedishmutated βAPP increased Ryanodine receptors (RyR) expression and enhanced RyR-mediated ER Ca2+ release in neuroblastoma cells as well as in transgenic mice [132].”
ResultSelf-citationThe DNA Damage Response in Neurons: Die by Apoptosis or Survive in a Senescence-Like State?
Fielder, E., von Zglinicki, T., & Jurk, D. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161221 · Cited by 126
Calcium channelopathies and Alzheimer's disease: Insight into therapeutic success and failures
Chakroborty, S., & Stutzmann, G. E. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.012 · Cited by 91
Memory formation and retention are affected in adult miR-132/212 knockout mice
Hernandez-Rapp, J., Smith, P. Y., Filali, M., Goupil, C., Planel, E., Magill, S. T., Goodman, R. H., & Hébert, S. S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.032 · Cited by 81
Ca2+ Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer’s Disease
McDaid, J., Mustaly-Kalimi, S., & Stutzmann, G. E. (2020) · Cells · doi:10.3390/cells9122655 · Cited by 73
Mustaly-Kalimi, S., Gallegos, W., Marr, R. A., Gilman-Sachs, A., Peterson, D. A., Sekler, I., & Stutzmann, G. E. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211999119 · Cited by 55
“Here, the mechanism may reflect the potentiation of APP phosphorylation through Ca-mediated positive regulation of β- and γ-secretase activities, and thus, normalizing Ca levels will result in the lowering of C99 and pathological Aβ production (36, 76).”
BackgroundExercise-Induced Modulation of Neuroinflammation in Models of Alzheimer’s Disease
Kelly, Á. M. (2018) · Brain Plasticity · doi:10.3233/bpl-180074 · Cited by 55
Webber, E. K., Fivaz, M., Stutzmann, G. E., & Griffioen, G. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13065 · Cited by 50
Malek, R., Arribas, R. L., Palomino-Antolin, A., Totoson, P., Demougeot, C., Kobrlova, T., Soukup, O., Iriepa, I., Moraleda, I., Diez-Iriepa, D., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00937 · Cited by 45
Gan, K. J., & Silverman, M. A. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-12-1612 · Cited by 41
Garcia, G., Pinto, S., Cunha, M., Fernandes, A., Koistinaho, J., & Brites, D. (2021) · Cells · doi:10.3390/cells10092424 · Cited by 39
“Some of these flaws have been tentatively surpassed by using the SH-SY5Y cell line overexpressing either WT human APP (APP695) or APP harboring the Swedish double mutation (K670N/M671L) [68].”
MethodZhang, H., Knight, C., Chen, S. R. W., & Bezprozvanny, I. (2023) · The Journal of Neuroscience · doi:10.1523/jneurosci.1820-22.2022 · Cited by 32
Liu, J., Lu, Y., Bhuiyan, P., Gruttner, J., St. Louis, L., Yi, Y., Liang, G., & Wei, H. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03816-x · Cited by 2
Metadata
- Authors
- Oulès, B., Del Prete, D., Greco, B., Zhang, X., Lauritzen, I., Sevalle, J., Moreno, S., Paterlini-Bréchot, P., Trebak, M., Checler, F., Benfenati, F., & Chami, M.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2012-08-22
- Volume
- 32
- Issue
- 34
- Pages
- 11820-11834
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1970049338
- Cited by
- 244
- References
- 5
- FWCI
- 8.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.